Skip to main content

The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa (2011) / Chapter Skim
Currently Skimming:

Appendix A: Agenda
Pages 95-102

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 95...
... Tuberculosis is today one of the leading causes of death in the world -- 4,500 people die daily from the disease. Although many cases of TB can be cured by available antibiotics, multidrug-resistant TB (MDR TB)
Read the entire page →
From page 96...
... The workshop will bring together disease experts, community leaders, policy makers, and patient advocates to examine the state of MDR TB in the South Africa region, to learn from the experiences of the South African public health community in its fight against MDR TB, and to draw lessons regarding best practices and novel approaches that can be applied both within and beyond the region. Proceedings of the workshop will be published and disseminated globally.
Read the entire page →
From page 97...
... Realities: Summary of 2008 MDR TB 9h30-9h45 Workshop in Washington, DC Gail Cassell, Eli Lilly and Company Session 1: A Realistic Assessment of the Spread of MDR/ 9h45-11h45 XDR TB in Sub-Saharan Africa with an Emphasis on South Africa Moderator: Gerald Friedland, Yale School of Medicine Capacity for Health Care Across Southern Africa and MDR/XDR TB Tomas Zimba, Maputo Central Hospital, Mozambique Evolution of XDR TB in KwaZulu-Natal Willem Sturm, Nelson Mandela School of Medicine, University of KwaZulu-Natal Prevalence of Drug Resistance at the Initiation of Second-Line Drugs and Existence of Totally Drug Resistant TB Martie van der Walt, Medical Research Council of South Africa
Read the entire page →
From page 98...
... 98 DRUG-RESISTANT TUBERCULOSIS IN SOUTHERN AFRICA Putting Resistance in Perspective: The Korean Experience and Polymorphisms Associated with Resistance and Cross Resistance Clifton Barry, National Institutes of Health Discussion with Audience 11h30-11h45 LUNCH 11h45-12h45 Keynote Address 12h45-13h45 Moderator: Janet Tobias, Ikana Media Epidemiology and Management of MDR TB in Children Simon Schaaf, Department of Paediatrics and Child Health, Stellenbosch University Discussion with Audience 13h30-13h45 Session 2: Coinfection with HIV/AIDS: Clinical 13h45-15h15 Outcomes and Consequences Moderator: Richard Chaisson, Center for Tuberculosis Research, Johns Hopkins University Tugela Ferry Experience in a Community Hospital Neel Gandhi, Tugela Ferry Care and Research Collaboration (TF CARES) Albert Einstein College of Medicine Outcomes from TB Referral Hospitals, KwaZulu-Natal Nesri Padayatchi, University of KwaZulu-Natal Outcomes from the Eastern Cape Charlotte Kvasnovsky, Medical Research Council Mortality and Causes of Death in South Africa Maletela Tuoane-Nkhasi, Statistics South Africa Discussion with Audience 15h00-15h15 BREAK 15h15-15h30
Read the entire page →
From page 99...
... Anne Goldfeld, Harvard University Discussion with Audience 16h45-17h00 ADJOURN 17h00 Group Dinner for Speakers 18h00 Day 2 March 4, 2010 Session 4: Transmission and Strategies for Infection 8h00-10h00 Control Moderator: Neel Gandhi, Tugela Ferry Care and Research Collaboration (TF CARES) Proof of Principle: Transmission of MDR TB in the AIR Facilities Matsie Mphahlele, Medical Research Council
Read the entire page →
From page 100...
... Farley, Johns Hopkins University Discussion with Audience 9h45-10h00 BREAK 10h00-10h30 Session 5: Application of Molecular Biology to Shape 10h30-12h15 Policy Moderator: Elaine Gallin, Doris Duke Charitable Foundation Drug-Resistant Genotypes: Implication for Point-of-Care Detection of Resistance in Different Geographies Paul van Helden, Stellenbosch University Genetic Analysis of Drug-Resistant Strains in South Africa Robin Warren, Stellenbosch University Bench to Bush in Biomarker Studies in Africa: Implications for MDR TB Treatment and Drug Development Shreemanta Parida, Max Planck Institute for Infection Biology, Berlin, Germany
Read the entire page →
From page 101...
... Where Are We and Where Do We Go from Here? Salim Abdool Karim, University of KwaZulu-Natal
Read the entire page →
From page 102...
... 102 DRUG-RESISTANT TUBERCULOSIS IN SOUTHERN AFRICA Panelist Response: Gail Cassell, Eli Lilly and Company Norbert Ndjeka, Department of Health, South Africa Sidney Parsons, Council for Scientific and Industrial Research Discussion with Audience 16h30-16h45 ADJOURN 17h00
Read the entire page →

Key Terms

  • southern africa
  • tugela ferry
  • martie van
  • van der
  • developing world

  • stellenbosch university
  • yale school
  • neel gandhi
  • ferry care
  • gail cassell

  • eli lilly
  • gerald friedland
  • der walt
  • draw lessons
  • mdr extends

  • lessons regarding
  • south african
  • growing threat
  • receiving appropriate
  • drug discovery

  • central hospital
  • willem sturm
  • growing understanding
  • africa meeting
  • commissioned paper

  • community leaders
  • poor countries
  • novel approaches
  • people die
  • primarily centered


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.